 |
 |
| Product ID |
Structure |
Product Name |
Purity |
Price |
Delete |
| JR6-L3148 |
 |
[1,1'-Binaphthalen]-2-ol, 6,6'-dibromo-2'-methoxy-, (1S)- (9CI) |
96%
|
|
Delete |
| JR6-L2242 |
 |
[1,1'-Biphenyl]-4-propanoic acid, ß-amino-, 1,1-dimethylethyl ester, (ßS)- |
96%
|
$780/1g, $2480/5g, $6980/25g |
Delete |
| AS-5263 |
 |
1,1'-Bi-2-naphthol |
98%
|
|
Delete |
| AS-1542 |
 |
1,2-Bis(diphenylphosphino)ethane |
98%
|
|
Delete |
| JR6-L7796 |
 |
1,2-Pyrrolidinedicarboxylic acid, 2-(trifluoromethyl)-, 1-(1,1-dimethylethyl) ester, (2R)- |
96%
|
$918/250mg, $1418/500mg, $1998/1g, $4980/5g, 10g, 25g |
Delete |
| AS-4337 |
 |
1-BROMO-2,6-DIMETHOXYBENZENE |
98%
|
|
Delete |
| AS-4355 |
 |
2-AMINO-4-FLUOROBENZONITRILE |
98%
|
|
Delete |
| A1-0744 |
 |
2-Bromo-5-nitropyridine |
98%
|
POA |
Delete |
| AS-4697 |
 |
2-Deoxy-D-glucose |
98%
|
|
Delete |
| AS-3563 |
 |
2-Ethylhexyl bromide |
98%
|
|
Delete |
| AS-2202 |
 |
2-Thiophenesulfonyl chloride |
98%
|
|
Delete |
| AS-5201 |
 |
4'-Methylbiphenyl-2-carboxylic acid |
98%
|
|
Delete |
| JR8-N1006 |
 |
4-(4-Hydroxyphenyl)-2-butanone |
98%
|
$400/20mg |
Delete |
| JR02-H005 |
 |
7-nitro-[1,2,4]triazolo[4,3-a]pyridine |
96%
|
|
Delete |
| JR8-N0579 |
 |
atractyloside A |
98%
|
|
Delete |
| AS-7285 |
 |
Conivaptan |
98%
|
|
Delete |
| JR8-N0593 |
 |
Curdione |
98%
|
|
Delete |
| AS-6796 |
 |
Ethyl 2,4,5-trifluorobenzoylacetate |
98%
|
|
Delete |
| JR02-H003 |
 |
imidazo[1,2-a]pyrimidin-2-amine |
96%
|
|
Delete |
| JR8-N1262 |
 |
Interiorin |
98% (HPLC)
|
|
Delete |
| JR8-N1225 |
 |
Kurarinone |
98% (HPLC)
|
$148/20mg, $518/100mg, $928/250mg, $1698/500mg, $2480/1g |
Delete |
| JR8-N1215 |
 |
Kushenol A |
98% (HPLC)
|
$398/5mg, 10mg, 20mg, 100mg, 500mg, 1g |
Delete |
| AS-7297 |
 |
Methyl 3-broMo-5-nitrobenzoate |
98%
|
|
Delete |
| JR6-L5512 |
 |
Oxazole, 2-chloro-5-methyl-4-phenyl- |
96%
|
|
Delete |
| JR8-N1126 |
 |
Psoralenoside |
98% (HPLC)
|
$298/5mg |
Delete |
| AS-7283 |
 |
Valganciclovir hydrochloride |
98%
|
|
Delete |
|
Continue browsing products
Quote/Order
Inquiry
|
|
|
 |
 |
 |